DAFTAR PUSTAKA

American Cancer Society, 2010, Guideline Ovarian Cancer, American Cancer Society
Berek JS, Hacker NF. 2010. Gynecologyc Oncology in chapter 11, Epithelial ovarian
cancer, 5th edition, Lippincott William&wilkins
Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. 2002. Survival
effect of maximal cytoreductive surgery for advance ovarian carcinoma a during
the platinum era: a meta-analysis. J Clin Oncol 2002: 1248-59.
Busman, B. 2008. Kanker Ovarium; in Aziz, M.F., Andrijono, Saifuddin, A.B., Buku
Acuan Nasional Onkologi. Edisi pertama. p. 468-527. Yayasan Bina Pustaka
Sarwono Prawirodihardjo, Jakarta
Choi,J.H., Wong, A.S.T., Huang, H.F., Leung, P.C. 2007. Gonadotropins and Ovarian
Cancer, Endocrine Reviews, 28 (4), 440-461.
Fauzan, R. 2009. Gambaran Faktor Risiko Penggunaan Kontrasepsi terhadap Angka
Kejadian Kanker Ovarium di RSUP Dr. Cipto Mangunkusumo Jakarta
Berdasarkan Pemeriksaan Histopatologik Tahun 2003-2007. Skripsi. Fakultas
Kedokteran Universitas Indonesia/Program Studi Pendidikan Dokter Umum.
Goodman MT, Howe HL, Tung KH. 2003. Incidence of ovarian cancer by race and
ethnicity in rhe united states. Journal of clinical oncology.
Havrilesky, Laura J; Gierisch, Jennifer M; Moorman, Patricia G, Coeytaux, remy R;
urrutia, rachel P; Lowery, William J; Dinan, Michaela; McBroom< Amanda J;
Wing, Liz; Musty, Michael D; Lallinger, Kathryn R; Hasselblad, Vic; Sanders,
Gillian D; Myers, E.R., 2013. Oral contraceptive use for the primary prevention
of ovarian cancer, Evid. Rep. Technol. Assess, Rockville: AHRQ, 212, pp. 1-
514
Hennessy BT, Coleman RL, Markman M. 2009. Ovarian cancer.
Lahmann, P.H. 2009. Anthropometric measures and epithelial ovarian cancer risk in
the European prospective investigation into cancer and nutrition. NCBI journal.
Vol 19.
Levine DA, De Los Santos J, Fleming G, Barakat RR, Markman M, Randal ME. 2010.
Ovarian cancer in Handbook for principles and practice of gynecologic oncology
.Lipincot williams wilkin.2010; p: 221-235
Rasjidi, I. 2010. Epidemiologi Kanker pada Wanita. 1st ed. Sagung Seto Jakarta.
Risch HA, MArret LD, Howe GR. 2012. Parity, contraception, infertility and the risk
of epithelial ovarian cancer. Amer. J. Epidemiol. 140, 585-597.
Salehi et al. 2008. Risk Factors for Ovarian Cancer: An Overview with Emphasis on
Hormonal Factors. Journal of Toxicology and Environmental Health Part
B 11(3-4):301-21
Schorge, J. 2008. At a Glanca Obstetri & Ginekologi. Edisi 2. Jakarta: Erlangga
Van Altena AM , Karim-Kos KE, de Vries E, Kruitwagen RFPM,Massuger LFAG,
Kiemeney LA. 2012. Trendsin therapy and survival of advanced stage epithelial
ovarian cancer patients in the Netherlands. Gynecologic Oncology 125 (2012)
649–654.
WHO. 2008. International agency of research and cancer.
Zhou, B. 2008. Hormone Replacement Therapy and Ovarian Cancer Risk: a
Metaanalysis. Cancer Research United Kingdom. 108 (3), 641-651.
Zorn KK, Awtrey CS, Gardner GJ. 2003 Gene expression profiles of serous,
endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Gynecol Oncol 88: A90